Ahmeadbad based Troikka Pharma on Wednesday said it has got a patent for Dynapar QPS, a novel pain relief formula.Troikaa Pharmaceuticals, a company with research focus on developing patented, said it had been administering clinical trial. “Based on the positive results of a clinical trial (Clinical Trial Registry Number CTRI/2105/02/ 005510),DCGI approved Dynapar QPS as a treatment for pain in osteoarthritis is the only topical pain killer approved by DCGI for this condition. Additionally, Dynapar QPS is approved for all kinds of musculoskeletal pains like backache, neck pain, knee pain etc,” the company said in a statement Wednesday.Dr Ketan R Patel, Chairman & Managing Director, Troikaa Pharmaceuticals Ltd said &”Dynapar QPS is a novel pain relief formula which provides quick powerful and long-lasting pain relief upon administration at the site of pain. Publications in scientific journals of repute confirm 5 times higher penetration of the pain killer Diclofenac through the skin as compared to the other topically used diclofenac formulations.”The Department of Science & Technology (India) had recognised Dynapar QPS for the successful commercialisation of indigenous technology by rewarding it with TDB (Technology Development Board) National Award in the year 2015, the company statement added.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!